Botta GP - Search Results

1

Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.

Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. Hurtado de Mendoza T, et al. Among authors: botta gp. Nat Commun. 2021 Mar 9;12(1):1541. doi: 10.1038/s41467-021-21858-1. Nat Commun. 2021. PMID: 33750829 Free PMC article.

2

Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC).

Elzein S, Bao F, Lin R, Schnickel G, Lowy AM, Botta GP. Elzein S, et al. Among authors: botta gp. BMC Gastroenterol. 2021 Sep 3;21(1):340. doi: 10.1186/s12876-021-01901-7. BMC Gastroenterol. 2021. PMID: 34479480 Free PMC article.

3

Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.

Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. Weitz J, et al. J Clin Oncol. 2024 Oct 16:JCO2400511. doi: 10.1200/JCO.24.00511. Online ahead of print. J Clin Oncol. 2024. PMID: 39413348

4

SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.

Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R. Botta GP, et al. JCI Insight. 2021 Sep 22;6(18):e150453. doi: 10.1172/jci.insight.150453. JCI Insight. 2021. PMID: 34375311 Free PMC article.

5

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy.

Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R. Louie BH, et al. NPJ Precis Oncol. 2022 Sep 22;6(1):67. doi: 10.1038/s41698-022-00309-0. NPJ Precis Oncol. 2022. PMID: 36138116 Free PMC article.

6

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients.

Botta GP, Huynh TR, Spierling-Bagsic SR, Agelidis A, Schaffer R, Lin R, Sigal D. Botta GP, et al. Cancer Med. 2023 Apr;12(7):7713-7723. doi: 10.1002/cam4.5523. Epub 2022 Dec 7. Cancer Med. 2023. PMID: 36478411 Free PMC article.

7

SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy.

Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R. Mardinian K, et al. Among authors: botta gp. Mol Cancer Ther. 2021 Dec;20(12):2341-2351. doi: 10.1158/1535-7163.MCT-21-0433. Epub 2021 Oct 12. Mol Cancer Ther. 2021. PMID: 34642211 Free PMC article. Review.

8

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.

Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, Botta GP, Catenacci DVT, Maron SB, Krinshpun S, Sharma S, George GV, Malhotra M, Jurdi A, Moshkevich S, Aleshin A, Kasi PM, Klempner SJ. Huffman BM, et al. Among authors: botta gp. JCO Precis Oncol. 2022 Dec;6:e2200420. doi: 10.1200/PO.22.00420. JCO Precis Oncol. 2022. PMID: 36480779 Free PMC article.

9

ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells.

Botta GP, Reichert M, Reginato MJ, Heeg S, Rustgi AK, Lelkes PI. Botta GP, et al. Neoplasia. 2013 Apr;15(4):359-72. doi: 10.1593/neo.121708. Neoplasia. 2013. PMID: 23555182 Free PMC article.

10

Advances on immunotherapy in genitourinary and renal cell carcinoma.

Botta GP, Granowicz E, Costantini C. Botta GP, et al. Transl Cancer Res. 2017 Feb;6(1):17-29. doi: 10.21037/tcr.2017.02.09. Transl Cancer Res. 2017. PMID: 28966917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters